Confirming the Diagnosis: Exams, EMG, and Genetics
At a Glance
Myotonia congenita is evaluated through symptom and family-history review, a physical exam for the warm-up phenomenon and percussion myotonia, EMG, CK testing, and genetic testing that can identify CLCN1 changes and distinguish Thomsen from Becker disease.
The path to a diagnosis for myotonia congenita involves a combination of your personal history, a physical examination, and specialized technical tests. Because muscle stiffness can be a symptom of several different conditions, doctors use a “staged” approach to move from clinical suspicion to a definitive answer [1][2].
The Clinical Consultation
The first step is a detailed review of your symptoms and family history. Your doctor will look for the hallmark “warm-up phenomenon”—stiffness that is worst after rest but improves with repeated movement [3]. During the exam, they may perform a percussion test, where they tap a muscle (often the thumb or tongue) with a reflex hammer to see if it dimples or stays contracted, which is a physical sign of myotonia [1].
They will also look for hypertrophy, which is the presence of unusually large, well-defined muscles that occur because the muscle is constantly “working” even when you think it is resting [4].
Needle Electromyography (EMG)
An Electromyography (EMG) test is often used to help confirm that your stiffness is caused by electrical “hyperexcitability” in the muscle fibers [2].
- The Procedure: A tiny, thin needle is inserted into various muscles to listen to their electrical activity.
- Myotonic Discharges: If you have myotonia congenita, the EMG will record “myotonic discharges.” These are bursts of electrical signals that rapidly change in pitch and volume [5].
- The “Dive-Bomber” Sound: To a neurologist, these signals sound like a WWII dive-bomber plane or a revving motorcycle [4]. While this confirms your muscles are hyperexcitable, it doesn’t name the specific gene responsible, as other conditions can also produce this sound [2].
Blood Tests and CK Levels
Your doctor may order a blood test to check your Creatine Kinase (CK) levels. CK is an enzyme that leaks into the blood when muscle fibers are stressed or damaged. In myotonia congenita, CK levels are typically normal or only mildly elevated (often about 2 to 4 times the normal limit) [3][6]. Very high CK levels are unusual for this condition and might suggest a different type of muscle disease [7].
Genetic Testing
While clinical findings and an EMG can support a diagnosis, genetic testing is the standard way to definitively confirm a molecular diagnosis and help distinguish between the Thomsen (dominant) and Becker (recessive) forms [1].
- CLCN1 Sequencing: This test looks for “spelling errors” in the CLCN1 gene.
- Multigene Panels: Often, doctors use a panel that tests several genes at once, including CLCN1, SCN4A (linked to sodium-channel myotonia), and genes related to myotonic dystrophy [8]. This is helpful because the symptoms of these conditions can look very similar [9].
- Deletion/Duplication Analysis (MLPA): Sometimes standard sequencing misses a “missing page” in the gene. A test called MLPA may be needed if doctors strongly suspect the Becker form but can only find one mutation instead of two [10].
- Variant of Uncertain Significance (VUS): A VUS means a gene change was found, but it is not known if it causes the disease. A VUS is not diagnostic. Your doctor may recommend testing family members to help interpret it [11].
Differentiating Similar Conditions
A key goal of testing is to rule out other conditions that cause myotonia:
- Sodium-Channel Myotonias (SCN4A): These are often triggered by eating potassium-rich foods or by cold, and they may affect the face more than the legs [12]. Paramyotonia congenita typically worsens with continued movement, rather than warming up.
- Myotonic Dystrophy (DM1/DM2): These are systemic diseases that cause muscle wasting, cataracts, and heart issues [2]. Genetic testing can help tell these apart from myotonia congenita [13]. Importantly, some repeat expansions in DM1/DM2 require dedicated testing and might be missed by an ordinary multigene sequencing panel.
Components of a Typical Diagnostic Evaluation
When you receive your results, ensure the following have been addressed to have a complete picture of your diagnosis:
- [ ] Clinical Exam: Confirmation of the “warm-up” phenomenon and presence of percussion myotonia [1].
- [ ] EMG Report: Documentation of myotonic discharges in various muscle groups [2].
- [ ] Genetic Evaluation: Identification of specific mutations in the CLCN1 gene [1].
- [ ] Inheritance Pattern: Clarity on whether the variants support a dominant or recessive pattern [14].
Common questions in this guide
How do doctors diagnose myotonia congenita?
What does a myotonic discharge mean on an EMG?
Which genetic tests are used for Thomsen and Becker disease?
What does a VUS mean in a myotonia congenita genetic report?
Are CK levels high in myotonia congenita?
How is myotonia congenita distinguished from similar conditions?
One line in your results can change your plan.
If genetic testing finds only a single change in a suspected Becker case, a deletion test called MLPA may be needed. We check your results against the latest research to help you prepare for what’s next.
Get notified when new evidence is published on Thomsen and Becker disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Diagnostics in skeletal muscle channelopathies.
Vicino A, Brugnoni R, Maggi L
Expert review of molecular diagnostics 2023; (23(12)):1175-1193 doi:10.1080/14737159.2023.2288258.
PMID: 38009256 - 2
Myotonia: Recognition, Evaluation, and Differential Diagnosis.
Crayle JI, Al-Lozi M, Miller TM
Muscle & nerve 2026; (74(4)):1174-1195 doi:10.1002/mus.70250.
PMID: 42108746 - 3
A case report: autosomal recessive Myotonia congenita caused by a novel splice mutation (c.1401 + 1G > A) in CLCN1 gene of a Chinese Han patient.
Miao J, Wei XJ, Liu XM, et al.
BMC neurology 2018; (18(1)):154 doi:10.1186/s12883-018-1153-x.
PMID: 30243293 - 4
Autosomal Recessive Myotonia Congenita in an Adolescent Boy With Novel Mutation: A Case Report With Discussion on Management.
Das P, Panigrahi D
Cureus 2024; (16(2)):e53981 doi:10.7759/cureus.53981.
PMID: 38469025 - 5
The needle EMG findings in myotonia congenita.
Nojszewska M, Lusakowska A, Gawel M, et al.
Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology 2019; (49()):102362 doi:10.1016/j.jelekin.2019.102362.
PMID: 31610484 - 6
Clinical and molecular characteristics of myotonia congenita in China: Case series and a literature review.
Li Y, Li M, Wang Z, et al.
Channels (Austin, Tex.) 2022; (16(1)):35-46 doi:10.1080/19336950.2022.2041292.
PMID: 35170402 - 7
Recessive myotonia congenita caused by a homozygous splice site variant in CLCN1 gene: a case report.
Sparber P, Sharova M, Filatova A, et al.
BMC medical genetics 2020; (21(Suppl 1)):197 doi:10.1186/s12881-020-01128-5.
PMID: 33092578 - 8
Myotonia congenita: mutation spectrum of CLCN1 in Spanish patients.
Milla CP, De Castro CP, Gómez-González C, et al.
Journal of genetics 2019; (98()).
PMID: 31544778 - 9
Non-dystrophic myotonias: clinical and mutation spectrum of 70 German patients.
Vereb N, Montagnese F, Gläser D, Schoser B
Journal of neurology 2021; (268(5)):1708-1720 doi:10.1007/s00415-020-10328-1.
PMID: 33263785 - 10
Clinical and Genetic Spectrum of Myotonia Congenita in Turkish Children.
Öz Tunçer G, Sanri A, Aydin S, et al.
Journal of neuromuscular diseases 2023; (10(5)):915-924 doi:10.3233/JND-230046.
PMID: 37355912 - 11
Myotonia congenita in a Greek cohort: Genotype spectrum and impact of the CLCN1:c.501C > G variant as a genetic modifier.
Marinakis NM, Svingou M, Papadimas GK, et al.
Muscle & nerve 2024; (70(2)):240-247 doi:10.1002/mus.28180.
PMID: 38855810 - 12
Clinical and Molecular Spectrum of Myotonia and Periodic Paralyses Associated With Mutations in SCN4A in a Large Cohort of Italian Patients.
Maggi L, Brugnoni R, Canioni E, et al.
Frontiers in neurology 2020; (11()):646 doi:10.3389/fneur.2020.00646.
PMID: 32849172 - 13
Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model.
Neault N, Ravel-Chapuis A, Baird SD, et al.
International journal of molecular sciences 2023; (24(4)) doi:10.3390/ijms24043794.
PMID: 36835205 - 14
Association of Three Different Mutations in the CLCN1 Gene Modulating the Phenotype in a Consanguineous Family with Myotonia Congenita.
Souza LS, Calyjur P, Ribeiro AF, et al.
Journal of molecular neuroscience : MN 2021; (71(11)):2275-2280 doi:10.1007/s12031-020-01785-4.
PMID: 33464536
This page is for informational purposes only and does not constitute medical advice. Your neurologist or genetics professional should interpret your EMG, CK level, and genetic results in the context of your symptoms and family history.